Originally published in icon Issue 1 2007
Full year profits for Anglo-Swedish pharmaceutical company Astra-Zeneca came in recently at over $8 BILLION. That was up about 30 per cent from last year. (Ed: This puts the comments of Imperial College’s Professor Waxman, in the November BMJ, into perspective when he complains that ‘Alternative medicine is big business, with a market value in the UK alone of £250 million…. and sales increase of 7 per cent per annum’).